Table 2

Selected treatment prescriptions for patient scenarios among paediatric and adult physicians

Paediatric physiciansAdult physicians
Scenario 1Scenario 2Scenario 3Scenario 1Scenario 2Scenario 3
N=30
(1 missing)
N=29
(2 missing)
N=28
(3 missing)
N=18N=18N=17
(1 missing)
Primary antibiotic
Intravenous ceftazidime11 (37%)13 (45%)1 (4%)7 (39%)8 (44%)8 (47%)
Intravenous ceftriaxone7 (23%)04 (14%)2 (11%)00
Intravenous ciprofloxacin000000
Intravenous piperacillin-tazobactam8 (27%)14 (48%)5 (18%)6 (33%)8 (44%)6 (35%)
Intravenous flucloxacillin1 (3%)06 (21%)001 (6%)
Intravenous cefepime1 (3%)1 (3%)12 (43%)1 (6%)1 (6%)1 (6%)
Other2 (7%)1 (3%)02 (11%)1 (6%)1 (6%)
Secondary antibiotic
None7 (23%)03 (11%)4 (22%)00
Intravenous tobramycin18 (60%)27 (93%)21 (75%)13 (72%)15 (83%)13 (76%)
Intravenous colistin1 (3%)00000
Intravenous gentamicin1 (3%)00000
Intravenous amikacin000000
Inhaled tobramycin01 (3%)01 (6%)2 (11%)2 (12%)
Inhaled colistin01 (3%)0000
Intravenous ciprofloxacin000000
Oral ciprofloxacin000000
Other3 (10%)04 (14%)01 (6%)2 (12%)
Reason for antibiotic selection
Professional opinion/clinical experience11 (37%)12 (41%)15 (54%)12 (66%)13 (72%)12 (70%)
Hospital or department policy7 (23%)8 (28%)5 (18%)1 (6%)2 (11%)2 (12%)
Advice from colleagues3 (10%)00000
Availability of medication2 (7%)001 (6%)2 (11%)1 (6%)
Concern for side effects001 (3%)000
Clinical familiarly with treatment3 (10%)3 (10%)2 (7%)1 (6%)1 (6%)2 (12%)
Other4 (13%)6 (21%)5 (18%)3 (16%)00
Third antibiotic
No29 (97%)27 (93%)23 (82%)18 (100%)10 (56%)14 (82%)
Yes1 (3%)2 (7%)5 (18%)08 (44%)3 (18%)
Chest physiotherapy
No1 (3%)0003 (17%)0
Yes, daily1 (3%)1 (3%)1 (4%)3 (17%)5 (28%)3 (18%)
Yes, BD27 (90.00%)26 (90%)24 (86%)14 (78%)9 (50%)12 (70%)
Yes, three times a day1 (3%)2 (7%)3 (10%)1 (5%)1 (6%)2 (12%)
Dornase alfa
Yes12 (40%)22 (76%)19 (68%)9 (50%)3 (17%)10 (59%)
No18 (60%)7 (24%)9 (32%)9 (50%)15 (83%)7 (41%)
Hypertonic saline
Yes24 (80%)25 (86%)26 (93%)16 (89%)7 (39%)16 (94%)
No6 (20%)4 (14%)2 (7%)2 (11%)11 (61%)1 (6%)
Oral prednisolone (short course)
Yes001 (4%)01 (6%)0
No30 (100%)29 (100%)27 (96%)18 (100%)17 (94%)17 (100%)
Change treatment if no response after 1‚ÄČweek
Yes29 (97%)26 (90%)25 (89%)18 (100%)17 (94%)14 (82%)
No1 (3%)3 (10%)3 (11%)01 (6%)3 (18%)
  • BD, two times per day.